Outcome parameter (ICD-9 codes)a | Validation algorithm | |
---|---|---|
Cardiovascular disease (410–414, 426–428, 430–438) | Ischemic heart disease (410–414) | • Evidence of angina pectoris symptoms or acute coronary syndrome, and/or • Imaging report (Angiography) |
Congestive heart failure (428) | • EF < 40 %, and/or • ≥3 dispensed prescriptions of diuretics, ACEI/ARB, or digoxin within six months following heart failure diagnosis [36] | |
Conduction disorders and cardiac dysrhythmias (426–427) | • Direct-current cardioversion-defibrillation, pacemakers implantable cardioverter-defibrillators, radiofrequency ablation, and/or • ≥3 dispensed prescriptions of antiarrhythmic agents within 6 months following event | |
Stroke (430–438) | • Hospitalization discharge sheet indicating a cerebral event, and/or • Imaging report (CT, PET, MRI), and/or • ≥3 dispensed prescriptions of anticoagulant agents within 6 months following event | |
Fractures (800–829) | • Imaging report (radiographs), and/or • Orthopedic referrals • Operations on the musculoskeletal system (ICD-9 codes 76–84) • Orthopedic aftercare (ICD-9 code V54) | |
Osteoporosis (733.0) | • Bone mineral density (T-score ≤ −2.5) [37], and/or • ≥1 dispensed prescriptions of bisphosphonates or estrogen agonist/antagonist (raloxifene) within 1 year following event | |
Diabetes (250) | • HbA1c level ≥6.5 %, or FPG ≥ 126 mg/dL, or 2-hour PG ≥200 mg/Dl [38], and/or • ≥3 dispensed prescriptions of insulin and oral diabetes medications within 6 months following diabetes diagnosis | |
Chronic painb | • Concordance with the Hebrew validated Short Form 36 (SF-36) [17] |